Silk Medical Aesthetics Inc. is a medical dermal filler company developing a versatile new platform designed for volume correction based on biocompatible, all-natural silk.
Silk Medical Aesthetics Inc. is a medical dermal filler company developing a versatile new platform designed for volume correction based on biocompatible, all-natural silk.
It is the first time silk has been used in volume correction, a breakthrough made possible by the company's patented invention of ACTIVATED SILKTM technology: pure, all-natural silk protein in liquid form. It’s anticipated to be the most biocompatible form of silk available today.
- The technology platform will aim to support multiple product indications as it is developed with a focus on advanced material properties that have not previously existed. The product portfolio is being designed for the eventual treatment of wrinkles and scars on the face, body and hands across a variety of skin depths.
- Bench studies have shown that natural silk may provide advanced product benefits, including: more precise control of swelling, decoupling of filler longevity from gel elasticity and cross-linking density, and advanced optical properties for superficial skin targeting.
- The platform is the company's first step toward creating new implantable natural biomaterial systems from ACTIVATED SILKTM technology, a sustainably manufactured product.
Product not available for sale. Clinical trials will begin in 2019.
Product not available for sale. Clinical trials will begin in 2019.
2019 Winner: Breakthrough Injection
2019 Winner: Breakthrough Injection
We founded Silk Medical Aesthetics to make medical products used in the skin safer and more effective by unlocking and applying the inherent properties of natural silk.
We founded Silk Medical Aesthetics to leverage the inherent power of natural silk to make medical products used in the skin safer and more effective.
Dr Gregory Altman
Co-Founder and CEO
A leading expert in natural silk biomaterials, Greg heads strategy and innovation at Silk Medical Aesthetics and concurrently serves as the CEO of Evolved By Nature. His extensive research into silk’s biocompatibility with the human body led to the creation of his first company, Serica Technologies, where he and Rebecca Lacouture, SMA’s co-founder, president and COO, developed the first FDA-approved silk-based medical device for soft tissue reconstruction. This breakthrough technology was acquired by Allergan, where Greg served as Vice President of Research and Development and General Manager. He is the inventor of several patents on clean silk technology and holds a PhD in Biotechnology Engineering and BS in Chemistry from Tufts University.
Dr Rebecca Lacouture
Co-Founder, President and COO
Our Board of Directors
Our Board of Directors
Greg Altman, PhD
Chief Executive Officer,
Evolved By Nature and
Silk Medical Aesthetics Inc.
Roy P. Disney
Private Investor and Philanthropist
Daniel A. Kraft
President/CEO IFP
Executive Vice President, The Kraft Group
Rebecca Lacouture, PhD
President and Chief Operating Officer,
Evolved By Nature and
Silk Medical Aesthetics Inc.
Robert W. Pangia
Private Investor
Robert W. Pangia
Private Investor
Jeffrey N. Vinik
CEO, American Investment Holdings
Chairman, Tampa Bay Sports & Entertainment
Jeff Vinik
CEO, American Investment Holdings Chairman, Tampa Bay Sports & Entertainment
Silk Medical Aesthetics Inc.